Firebird Biomolecular Sciences, LLC

Firebird Biomolecular Sciences, LLC, founded in 2005, is a biotechnology research company based in Alachua, Florida, that supplies innovative nucleic acid components and molecular tools for synthetic biology, research, and clinical diagnostics. The company develops and provides specialized reagents, including artificially expanded genetic information systems (AEGIS), self-avoiding molecular recognition systems (SAMRS), reversible terminators, and modified nucleosides, phosphoramides, and polymerases. These technologies are designed to enhance DNA sequencing, oligo synthesis, and multiplexing capabilities by addressing challenges related to sequence divergence and binding specificity through advanced molecular engineering.

The company serves researchers and commercial partners in the healthcare and biotechnology sectors by providing tools that improve the precision and efficiency of genetic analysis and synthetic biology workflows. Their product suite, which includes custom genomic databases and interpretative genomics services, aims to solve complex laboratory and clinical problems. By leveraging expanded genetic alphabets and unique DNA-based technologies, Firebird supports the development of new biomedical innovations, ranging from advanced diagnostic assays to therapeutic applications, with a commitment to providing high-quality, state-of-the-art reagents for cutting-edge scientific research.